All stock lists
BioNexus Gene Lab Corp (NASDAQ:BGLC)
MY · Delayed Price · Currency is USD
Industrials · Industrial - Distribution
1.16-0.03 (-2.52%)
Insider Score
––Not scored
BGLC Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BGLC Stock Insider Trading Activity
BGLC stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Tan Lee Su-Leng CEO | Award | 338,709 | — | — | New | 338,709 | Aug 13, 2026 | — | Form 4 |
| Yap Chee Keong Director | Award | 32,258 | — | — | New | 32,258 | Aug 13, 2026 | — | Form 4 |
| Bin Abdul Hamid Muhammad Azrul Director | Award | 32,258 | — | — | New | 32,258 | Aug 13, 2026 | — | Form 4 |
| Chong Set Fui CFO | Award | 96,774 | — | — | New | 96,774 | Aug 13, 2026 | — | Form 4 |
| Low Jook Yuen Director | Award | 16,129 | — | — | 1279% | 17,390 | Aug 13, 2026 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.